Comments to FDA: Remote Regulatory Assessments Draft Guidance Share page: Docket Number: FDA-2022-D-0810 CHPA appreciates the opportunity to provide comments on FDA Remote Regulatory Assessments Draft Guidance. Download Document Issues: OTC Medicines Dietary Supplements Consumer Medical Devices Related Posts Articles Polibrief: Consumer Data Privacy: State Efforts to Preserve Privacy Apr 16, 2024 Press Releases and Statements Self-Care Industry Representatives Participate in Capitol Hill Briefing Highlighting Legislative Priorities Apr 11, 2024 Press Releases and Statements Kentucky Expands Access to OTC Cold & Allergy Medications Containing PSE Apr 8, 2024